Kawasaki, Japan

Hideyuki Shirae


Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1989-1990

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Hideyuki Shirae

Introduction

Hideyuki Shirae is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of important pharmaceutical compounds. With a total of 4 patents, his work has had a considerable impact on medical research and development.

Latest Patents

Shirae's latest patents include a method of producing 2',3'-dideoxyinosine. This method involves contacting 2',3'-dideoxyadenosine with a microorganism capable of converting the substrate into 2',3'-dideoxyinosine. Another significant patent is related to methods for producing ribose-1-phosphoric acid and ribavirin. This invention utilizes microorganisms to produce ribavirin and ribose-1-phosphoric acid, which is a precursor of ribavirin. The methods involve specific microorganisms and chemical compounds to achieve the desired results.

Career Highlights

Throughout his career, Hideyuki Shirae has worked with prominent companies such as Ajinomoto Co., Ltd. and Ajinomoto Co., Inc., specifically in the Patent & Licensing Department. His expertise in biotechnology and patenting has allowed him to contribute to various innovative projects.

Collaborations

Shirae has collaborated with notable coworkers, including Kenzo Yokozeki and Hiroshi Shiragami. Their combined efforts have led to advancements in the field of biotechnology and pharmaceuticals.

Conclusion

Hideyuki Shirae's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical research and pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…